These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20237938)

  • 1. Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.
    Mihaljevic AL; Michalski CW; Friess H; Kleeff J
    Langenbecks Arch Surg; 2010 Apr; 395(4):295-308. PubMed ID: 20237938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
    Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
    J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
    Giovannetti E; van der Borden CL; Frampton AE; Ali A; Firuzi O; Peters GJ
    Semin Cancer Biol; 2017 Jun; 44():43-59. PubMed ID: 28438662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
    Keklikoglou I; Hosaka K; Bender C; Bott A; Koerner C; Mitra D; Will R; Woerner A; Muenstermann E; Wilhelm H; Cao Y; Wiemann S
    Oncogene; 2015 Sep; 34(37):4867-78. PubMed ID: 25500542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells.
    Dumartin L; Quemener C; Laklai H; Herbert J; Bicknell R; Bousquet C; Pyronnet S; Castronovo V; Schilling MK; Bikfalvi A; Hagedorn M
    Gastroenterology; 2010 Apr; 138(4):1595-606, 1606.e1-8. PubMed ID: 20080097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.
    Zeleniak AE; Huang W; Brinkman MK; Fishel ML; Hill R
    Oncotarget; 2017 Mar; 8(10):16473-16487. PubMed ID: 28146435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotrophic factor artemin promotes pancreatic cancer invasion.
    Ceyhan GO; Giese NA; Erkan M; Kerscher AG; Wente MN; Giese T; Büchler MW; Friess H
    Ann Surg; 2006 Aug; 244(2):274-81. PubMed ID: 16858191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
    He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
    Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on molecular research of pancreatic adenocarcinoma.
    Krautz C; Rückert F; Saeger HD; Pilarsky C; Grützmann R
    Anticancer Agents Med Chem; 2011 Jun; 11(5):411-7. PubMed ID: 21492076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between high levels of Notch3 expression and high invasion and poor overall survival rates in pancreatic ductal adenocarcinoma.
    Zhou JX; Zhou L; Li QJ; Feng W; Wang PM; Li EF; Gong WJ; Kou MW; Gou WT; Yang YL
    Oncol Rep; 2016 Nov; 36(5):2893-2901. PubMed ID: 27633819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
    Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.
    Wan C; Gong C; Zhang H; Hua L; Li X; Chen X; Chen Y; Ding X; He S; Cao W; Wang Y; Fan S; Xiao Y; Zhou G; Shen A
    Cancer Lett; 2016 Apr; 373(1):67-76. PubMed ID: 26803058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin.
    Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J
    Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.